Guggenheim Capital LLC Sells 13,343 Shares of HCA Healthcare, Inc. (NYSE:HCA)

Guggenheim Capital LLC trimmed its stake in HCA Healthcare, Inc. (NYSE:HCA - Free Report) by 56.3% during the fourth quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 10,361 shares of the company's stock after selling 13,343 shares during the period. Guggenheim Capital LLC's holdings in HCA Healthcare were worth $3,110,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors have also modified their holdings of HCA. Whipplewood Advisors LLC bought a new position in HCA Healthcare in the 4th quarter valued at $31,000. Tidemark LLC acquired a new stake in shares of HCA Healthcare in the fourth quarter valued at approximately $36,000. Activest Wealth Management grew its holdings in shares of HCA Healthcare by 1,250.0% in the 4th quarter. Activest Wealth Management now owns 135 shares of the company's stock valued at $40,000 after acquiring an additional 125 shares in the last quarter. Pinnacle Bancorp Inc. boosted its holdings in shares of HCA Healthcare by 50.0% in the 4th quarter. Pinnacle Bancorp Inc. now owns 150 shares of the company's stock valued at $45,000 after buying an additional 50 shares during the last quarter. Finally, Eastern Bank acquired a new stake in HCA Healthcare in the 4th quarter valued at about $62,000. Institutional investors and hedge funds own 62.73% of the company's stock.

Wall Street Analyst Weigh In

HCA has been the subject of a number of research analyst reports. KeyCorp lowered their price target on HCA Healthcare from $420.00 to $370.00 and set an "overweight" rating for the company in a report on Tuesday, January 7th. Baird R W downgraded HCA Healthcare from a "strong-buy" rating to a "hold" rating in a research note on Tuesday, April 15th. Robert W. Baird reaffirmed a "neutral" rating and set a $336.00 price target (down from $396.00) on shares of HCA Healthcare in a research report on Tuesday, April 15th. Truist Financial cut their price objective on shares of HCA Healthcare from $430.00 to $390.00 and set a "buy" rating for the company in a research report on Monday, January 6th. Finally, Bank of America dropped their target price on HCA Healthcare from $380.00 to $370.00 and set a "buy" rating for the company in a report on Monday, January 27th. One research analyst has rated the stock with a sell rating, seven have assigned a hold rating, eleven have given a buy rating and one has given a strong buy rating to the company. According to MarketBeat.com, the company has an average rating of "Moderate Buy" and a consensus price target of $381.67.

Insider Activity at HCA Healthcare

In related news, SVP Jennifer Berres sold 9,533 shares of the firm's stock in a transaction dated Friday, February 14th. The shares were sold at an average price of $322.59, for a total transaction of $3,075,250.47. Following the transaction, the senior vice president now directly owns 15,412 shares of the company's stock, valued at approximately $4,971,757.08. This trade represents a 38.22 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. 1.30% of the stock is owned by insiders.

HCA Healthcare Stock Down 4.7 %

HCA traded down $16.18 on Friday, reaching $325.24. 1,443,959 shares of the company traded hands, compared to its average volume of 1,393,555. The company has a market cap of $80.07 billion, a price-to-earnings ratio of 14.73, a PEG ratio of 1.10 and a beta of 1.48. The stock's 50 day moving average price is $329.61 and its 200-day moving average price is $332.87. The company has a debt-to-equity ratio of 69.07, a current ratio of 1.08 and a quick ratio of 0.97. HCA Healthcare, Inc. has a 52-week low of $289.98 and a 52-week high of $417.14.

HCA Healthcare (NYSE:HCA - Get Free Report) last posted its quarterly earnings results on Friday, April 25th. The company reported $6.45 EPS for the quarter, beating the consensus estimate of $5.77 by $0.68. The firm had revenue of $18.32 billion during the quarter, compared to analysts' expectations of $18.26 billion. HCA Healthcare had a return on equity of 586.47% and a net margin of 8.16%. During the same quarter in the prior year, the firm posted $5.36 EPS. On average, sell-side analysts expect that HCA Healthcare, Inc. will post 24.98 EPS for the current fiscal year.

HCA Healthcare Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Monday, June 30th. Investors of record on Monday, June 16th will be paid a $0.72 dividend. This represents a $2.88 dividend on an annualized basis and a yield of 0.89%. HCA Healthcare's payout ratio is presently 13.11%.

HCA Healthcare Company Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.